Ajooni Biotech Limited (NSE:AJOONI)

Ajooni Biotech Revenue

Ajooni Biotech had revenue of 637.60M INR in the quarter ending June 30, 2026, with 99.79% growth. This brings the company's revenue in the last twelve months to 2.17B, up 76.16% year-over-year. In the fiscal year ending March 31, 2026, Ajooni Biotech had annual revenue of 1.85B with 59.48% growth.

• Revenue (ttm): 2.17B
• Revenue Growth: +76.16%
• P/S Ratio: 0.30
• Revenue / Employee: n/a
• Employees: 134
• Market Cap: 640.75M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.85B	689.25M	59.48%
Mar 31, 2025	1.16B	356.18M	44.38%
Mar 31, 2024	802.54M	57.66M	7.74%
Mar 31, 2023	744.88M	4.50M	0.61%
Mar 31, 2022	740.38M	229.99M	45.06%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error